Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis.
Tatsumi Y, Kakimoto K, Hara A, Mizuta N, Numa K, Kinoshita N, Nakazawa K, Koshiba R, Hirata Y, Ota K, Miyazaki T, Nakamura S, Sakagami K, Arimitsu S, Ito H, Nishikawa H. Tatsumi Y, et al. Among authors: mizuta n. J Clin Med. 2023 Nov 18;12(22):7165. doi: 10.3390/jcm12227165. J Clin Med. 2023. PMID: 38002777 Free PMC article.
Comparing the Effects of Anti-TNF Agent and Ustekinumab on Small Bowel Inflammation in Crohn's Disease: Inverse Probability Weighting With Stabilized Weights of Propensity Scores.
Hirata Y, Nishioka D, Nishida K, Shimizu H, Mizuta N, Numa K, Nakazawa K, Kakimoto K, Miyazaki T, Nakamura S, Nishikawa H. Hirata Y, et al. Among authors: mizuta n. Crohns Colitis 360. 2024 May 14;6(2):otae033. doi: 10.1093/crocol/otae033. eCollection 2024 Apr. Crohns Colitis 360. 2024. PMID: 38864024 Free PMC article.
Correction: Tatsumi et al. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. J. Clin. Med. 2023, 12, 7165.
Tatsumi Y, Kakimoto K, Hara A, Mizuta N, Numa K, Kinoshita N, Nakazawa K, Koshiba R, Hirata Y, Ota K, Miyazaki T, Nakamura S, Sakagami K, Arimitsu S, Ito H, Nishikawa H. Tatsumi Y, et al. Among authors: mizuta n. J Clin Med. 2024 Jul 4;13(13):3923. doi: 10.3390/jcm13133923. J Clin Med. 2024. PMID: 38999556 Free PMC article.
Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study.
Tomida T, Kimura T, Yamamoto K, Uda A, Matsumoto Y, Tamura N, Iida M, Tanifuji A, Matsumoto K, Mizuta N, Ebisawa K, Ohji G, Omura T, Iwata K, Yano I. Tomida T, et al. Among authors: mizuta n. J Pharm Health Care Sci. 2024 Sep 3;10(1):54. doi: 10.1186/s40780-024-00376-4. J Pharm Health Care Sci. 2024. PMID: 39227983 Free PMC article.
Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer.
Kato C, Iizuka-Ohashi M, Honda M, Konishi E, Yokota I, Boku S, Mizuta N, Morita M, Sakaguchi K, Taguchi T, Watanabe M, Naoi Y. Kato C, et al. Among authors: mizuta n. Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167458. doi: 10.1016/j.bbadis.2024.167458. Epub 2024 Aug 10. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 39128642 Free article.
99 results